123 related articles for article (PubMed ID: 7584093)
1. Inflammatory effects of gene transfer into the CNS with defective HSV-1 vectors.
Wood MJ; Byrnes AP; Pfaff DW; Rabkin SD; Charlton HM
Gene Ther; 1994 Sep; 1(5):283-91. PubMed ID: 7584093
[TBL] [Abstract][Full Text] [Related]
2. Immunological consequences of HSV-1-mediated gene transfer into the CNS.
Wood MJ; Byrnes AP; Rabkin SD; Pfaff DW; Charlton HM
Gene Ther; 1994; 1 Suppl 1():S82. PubMed ID: 8542428
[TBL] [Abstract][Full Text] [Related]
3. Specific patterns of defective HSV-1 gene transfer in the adult central nervous system: implications for gene targeting.
Wood MJ; Byrnes AP; Kaplitt MG; Pfaff DW; Rabkin SD; Charlton HM
Exp Neurol; 1994 Nov; 130(1):127-40. PubMed ID: 7821388
[TBL] [Abstract][Full Text] [Related]
4. [Expression of foreign genes in adult rats' central nervous system by use of defective herpes simplex virus type 1 vectors].
Yang T; Wang X; Yan Z; Hou Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec; 11(4):306-10. PubMed ID: 15617234
[TBL] [Abstract][Full Text] [Related]
5. Delivery of herpes simplex virus amplicon-based vectors to the dentate gyrus does not alter hippocampal synaptic transmission in vivo.
Dumas T; McLaughlin J; Ho D; Meier T; Sapolsky R
Gene Ther; 1999 Oct; 6(10):1679-84. PubMed ID: 10516716
[TBL] [Abstract][Full Text] [Related]
6. Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors.
Scarpini CG; May J; Lachmann RH; Preston CM; Dunnett SB; Torres EM; Efstathiou S
Gene Ther; 2001 Jul; 8(14):1057-71. PubMed ID: 11526453
[TBL] [Abstract][Full Text] [Related]
7. Potential and limitations of a gamma 34.5 mutant of herpes simplex 1 as a gene therapy vector in the CNS.
McMenamin MM; Byrnes AP; Pike FG; Charlton HM; Coffin RS; Latchman DS; Wood MJ
Gene Ther; 1998 May; 5(5):594-604. PubMed ID: 9797863
[TBL] [Abstract][Full Text] [Related]
8. Inducible gene expression of the human immunodeficiency virus LTR in a replication-incompetent herpes simplex virus vector.
Warden MP; Weir JP
Virology; 1996 Dec; 226(1):127-31. PubMed ID: 8941330
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
10. Muscle derived cell mediated ex vivo gene transfer to the lower urinary tract: comparison of viral vectors.
Pruchnic R; Yokoyama T; Lee JY; Huard J; Chancellor MB
Urol Res; 2002 Oct; 30(5):310-6. PubMed ID: 12389119
[TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus-mediated gene delivery to the rodent visual system.
Spencer B; Agarwala S; Miskulin M; Smith M; Brandt CR
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1392-401. PubMed ID: 10798655
[TBL] [Abstract][Full Text] [Related]
12. Gene transfer into the central nervous system using herpes simplex virus-1 vectors.
Tabbaa S; Goulah C; Tran RK; Lis A; Korody R; Stachowski B; Horowitz JM; Torres G; Stachowiak EK; Bloom DC; Stachowiak MK
Folia Morphol (Warsz); 2000; 59(4):221-32. PubMed ID: 11107692
[TBL] [Abstract][Full Text] [Related]
13. Gene transfer into enteric neurons of the rat small intestine in organ culture using a replication defective recombinant herpes simplex virus type 1 (HSV1) vector, but not recombinant adenovirus vectors.
Brown OA; Santer RM; Shering AF; Larregina AT; Morelli AE; Southgate TD; Castro MG; Lowenstein PR
Gene Ther; 1997 Apr; 4(4):331-8. PubMed ID: 9176519
[TBL] [Abstract][Full Text] [Related]
14. Combined HSV-1 recombinant and amplicon piggyback vectors: replication-competent and defective forms, and therapeutic efficacy for experimental gliomas.
Pechan PA; Herrlinger U; Aghi M; Jacobs A; Breakefield XO
J Gene Med; 1999; 1(3):176-85. PubMed ID: 10738566
[TBL] [Abstract][Full Text] [Related]
15. Herpes simplex virus type 1 vector mediated gene transfer to muscle.
Huard J; Goins WF; Glorioso JC
Gene Ther; 1995 Aug; 2(6):385-92. PubMed ID: 7584113
[TBL] [Abstract][Full Text] [Related]
16. Integration of active human beta-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector.
Oehmig A; Cortés ML; Perry KF; Sena-Esteves M; Fraefel C; Breakefield XO
Gene Ther; 2007 Jul; 14(14):1078-91. PubMed ID: 17460718
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo hepatic gene transfer in mouse using a defective herpes simplex virus-1 vector.
Lu B; Gupta S; Federoff H
Hepatology; 1995 Mar; 21(3):752-9. PubMed ID: 7875674
[TBL] [Abstract][Full Text] [Related]
18. Long-term persistence of defective HSV-1 vectors in the rat brain is demonstrated by reactivation of vector gene expression.
Starr PA; Lim F; Grant FD; Trask L; Lang P; Yu L; Geller AI
Gene Ther; 1996 Jul; 3(7):615-23. PubMed ID: 8818649
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of genomic HSV vectors for gene delivery to motor neurons following peripheral inoculation in vivo.
Perez MC; Hunt SP; Coffin RS; Palmer JA
Gene Ther; 2004 Jul; 11(13):1023-32. PubMed ID: 15164091
[TBL] [Abstract][Full Text] [Related]
20. Herpes simplex virus vector-mediated dystrophin gene transfer and expression in MDX mouse skeletal muscle.
Akkaraju GR; Huard J; Hoffman EP; Goins WF; Pruchnic R; Watkins SC; Cohen JB; Glorioso JC
J Gene Med; 1999; 1(4):280-9. PubMed ID: 10738561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
